$HIMS 🚨 FULL INTERVIEW: Raphaël Mazoyer, Finnrick CEO (@raphal) Raphaël runs Finnrick @finnrick_tests, the peptide testing company that has become the de facto rating agency of the peptide industry Interestingly, he says peptides have spread across America faster than any Silicon Valley trend he's ever been a part of He explains why BPC-157 and CJC-1295 scores are so far below retatrutide scores, and what was actually in the Brooklyn bodega vials Wired sent him (they weren't peptides) We also discuss China's peptide manufacturing prowess. Raphaël thinks China is simply very good at making peptides, and that even with new US plants, America may not yet have the people or the experience to match Chinese quality 01:24 - 18,000 tests 02:32 - Peptides spread past SF, LA, and New York fast 05:52 - Finnrick mystery shopping 12:41 - Why no BPC-157 vendor scores above 90% 17:47 - Brooklyn bodega "peptides" are not peptides 🤯 21:32 - Peptide quality 22:10 - Is Finnrick pay to play? 24:53 - Impact to Finnrick if peptides are moved to Cat 1 26:51 - "Zero doubt" the gray market gets bigger 30:54 - Why China may make better peptides than the US 35:12 - US market size today 37:06 - Market will 5-10x by 2030 Not financial, legal, or medical advice